FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896426525> ?p ?o ?g. }

• W2896426525 endingPage "3867" @default.
• W2896426525 startingPage "3856" @default.
• W2896426525 abstract "Abstract BACKGROUND The lifetime risk of developing leukemia in the United States is 1.5%. There are challenges in the estimation of population‐based survival using registry data because treatments and prognosis vary greatly by subtype. The objective of the current study was to determine leukemia survival estimates in the United States from 1995 to 2009 according to subtype, sex, geographical area, and race. METHODS Five‐year net survival was estimated using data for 370,994 patients from 43 registries in 37 states and in 6 metropolitan areas, covering approximately 81% of the adult (15‐99 years) US population. Leukemia was categorized according to principal subtype (chronic lymphocytic leukemia, acute myeloid leukemia, and acute lymphocytic leukemia), and subcategorized in accordance with the HAEMACARE protocol. We analyzed age‐standardized 5‐year net survival by calendar period (1995‐1999, 2000‐2004, and 2005‐2009), leukemia subtype, sex, race, and US state. RESULTS The age‐standardized 5‐year net survival estimates increased from 45.0% for patients diagnosed during 1995‐1999 to 49.0% for those diagnosed during 2000‐2004 and 52.0% for those diagnosed during 2005‐2009. For patients diagnosed during 2005‐2009, 5‐year survival was 18.2% (95% confidence interval [95% CI], 17.8%‐18.6%) for acute myeloid leukemia, 44.0% (95% CI, 43.2%‐44.8%) for acute lymphocytic leukemia, and 77.3% (95% CI, 76.9%‐77.7%) for chronic lymphocytic leukemia. For nearly all leukemia subtypes, survival declined in successive age groups above 45 to 54 years. Men were found to have slightly lower survival than women; however, this discrepancy was noted to have fallen in successive calendar periods. Net survival was substantially higher in white than black patients in all calendar periods. There were large differences in survival noted between states and metropolitan areas. CONCLUSIONS Survival from leukemia in US adults improved during 1995‐2009. Some geographical differences in survival may be related to access to care. We found disparities in survival by sex and between black and white patients." @default.
• W2896426525 created "2018-10-26" @default.
• W2896426525 creator A5001355939 @default.
• W2896426525 creator A5002540582 @default.
• W2896426525 creator A5018872980 @default.
• W2896426525 creator A5038448560 @default.
• W2896426525 creator A5046354949 @default.
• W2896426525 creator A5047070788 @default.
• W2896426525 creator A5064873293 @default.
• W2896426525 creator A5065861382 @default.
• W2896426525 creator A5080307172 @default.
• W2896426525 date "2018-10-01" @default.
• W2896426525 modified "2023-10-11" @default.
• W2896426525 title "Adult leukemia survival trends in the United States by subtype: A population-based registry study of 370,994 patients diagnosed during 1995-2009" @default.
• W2896426525 cites W150562284 @default.
• W2896426525 cites W1505869172 @default.
• W2896426525 cites W172437910 @default.
• W2896426525 cites W1746808197 @default.
• W2896426525 cites W1911579929 @default.
• W2896426525 cites W1979715239 @default.
• W2896426525 cites W2026969299 @default.
• W2896426525 cites W2057721627 @default.
• W2896426525 cites W206701898 @default.
• W2896426525 cites W2070728536 @default.
• W2896426525 cites W2077720730 @default.
• W2896426525 cites W2081169791 @default.
• W2896426525 cites W2109584286 @default.
• W2896426525 cites W2110013351 @default.
• W2896426525 cites W2112657305 @default.
• W2896426525 cites W2115906186 @default.
• W2896426525 cites W2120963080 @default.
• W2896426525 cites W2140056658 @default.
• W2896426525 cites W2148854558 @default.
• W2896426525 cites W2156449340 @default.
• W2896426525 cites W2162885909 @default.
• W2896426525 cites W2284771340 @default.
• W2896426525 cites W2297968909 @default.
• W2896426525 cites W2326175431 @default.
• W2896426525 cites W2464037156 @default.
• W2896426525 cites W2787553551 @default.
• W2896426525 doi "https://doi.org/10.1002/cncr.31674" @default.
• W2896426525 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6392057" @default.
• W2896426525 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30343495" @default.
• W2896426525 hasPublicationYear "2018" @default.
• W2896426525 type Work @default.
• W2896426525 sameAs 2896426525 @default.
• W2896426525 citedByCount "28" @default.
• W2896426525 countsByYear W28964265252019 @default.
• W2896426525 countsByYear W28964265252020 @default.
• W2896426525 countsByYear W28964265252021 @default.
• W2896426525 countsByYear W28964265252022 @default.
• W2896426525 countsByYear W28964265252023 @default.
• W2896426525 crossrefType "journal-article" @default.
• W2896426525 hasAuthorship W2896426525A5001355939 @default.
• W2896426525 hasAuthorship W2896426525A5002540582 @default.
• W2896426525 hasAuthorship W2896426525A5018872980 @default.
• W2896426525 hasAuthorship W2896426525A5038448560 @default.
• W2896426525 hasAuthorship W2896426525A5046354949 @default.
• W2896426525 hasAuthorship W2896426525A5047070788 @default.
• W2896426525 hasAuthorship W2896426525A5064873293 @default.
• W2896426525 hasAuthorship W2896426525A5065861382 @default.
• W2896426525 hasAuthorship W2896426525A5080307172 @default.
• W2896426525 hasBestOaLocation W28964265251 @default.
• W2896426525 hasConcept C121608353 @default.
• W2896426525 hasConcept C126322002 @default.
• W2896426525 hasConcept C2777938653 @default.
• W2896426525 hasConcept C2778461978 @default.
• W2896426525 hasConcept C2778527826 @default.
• W2896426525 hasConcept C2778729363 @default.
• W2896426525 hasConcept C2781107101 @default.
• W2896426525 hasConcept C2908647359 @default.
• W2896426525 hasConcept C2909962599 @default.
• W2896426525 hasConcept C44249647 @default.
• W2896426525 hasConcept C71924100 @default.
• W2896426525 hasConcept C99454951 @default.
• W2896426525 hasConceptScore W2896426525C121608353 @default.
• W2896426525 hasConceptScore W2896426525C126322002 @default.
• W2896426525 hasConceptScore W2896426525C2777938653 @default.
• W2896426525 hasConceptScore W2896426525C2778461978 @default.
• W2896426525 hasConceptScore W2896426525C2778527826 @default.
• W2896426525 hasConceptScore W2896426525C2778729363 @default.
• W2896426525 hasConceptScore W2896426525C2781107101 @default.
• W2896426525 hasConceptScore W2896426525C2908647359 @default.
• W2896426525 hasConceptScore W2896426525C2909962599 @default.
• W2896426525 hasConceptScore W2896426525C44249647 @default.
• W2896426525 hasConceptScore W2896426525C71924100 @default.
• W2896426525 hasConceptScore W2896426525C99454951 @default.
• W2896426525 hasIssue "19" @default.
• W2896426525 hasLocation W28964265251 @default.
• W2896426525 hasLocation W28964265252 @default.
• W2896426525 hasLocation W28964265253 @default.
• W2896426525 hasLocation W28964265254 @default.
• W2896426525 hasLocation W28964265255 @default.
• W2896426525 hasOpenAccess W2896426525 @default.
• W2896426525 hasPrimaryLocation W28964265251 @default.
• W2896426525 hasRelatedWork W1538058163 @default.
• W2896426525 hasRelatedWork W2039373021 @default.
• W2896426525 hasRelatedWork W2181510334 @default.

• next